Society Council

John Zhong

Council Member

Dr. John Zhong is the Vice President of Biometrics at REGENXBIO, a leading gene therapy company. Before joining REGENXBIO, he was a Biostatistics Group Head at Biogen, leading his teams to provide statistical strategy and support for Early Development, Immunology, and Rare Disease in all phases of clinical development. He also led the Innovative Analytics group and played a critical role in the use of innovative statistical methods and trial designs across multiple assets. Prior to Biogen, John was a Senior Director at Human Genome Sciences, accountable for statistical strategy and support to all phases of clinical development in autoimmune disease and infectious disease areas. His work has brought multiple new treatments to patients with serious unmet needs.

In the industry, John actively promoted statistical innovation in drug development and brought industry’s voice to regulatory innovation. John served in FDA’s expert panel for the public meeting on “Promoting the Use of Complex Innovative Designs in Clinical Trials”. He made a positive impact on the design of FDA’s Complex Innovative Designs Pilot program. Currently, John is a Rapporteur at the ICH, leading the E20 Expert Working Group to develop an international regulatory guideline on Adaptive Clinical Trials. John received his PhD in Mathematical Statistics from the University of Maryland at College Park. He has coauthored over 50 manuscripts in peer reviewed medical and statistical journals and more than 100 presentations.

Copyright © NESS 2024